Artificial Intelligence Detects Cardiac Amyloidosis Before Clinical Diagnosis
Authors:
- Victoria YuanVYVictoria Yuan
- Saisanjana KalagaraSKSaisanjana Kalagara
- Hirotaka IekiHIHirotaka Ieki
- Ankeet S. BhattABAnkeet S. Bhatt
- Andrew P. AmbrosyAAAndrew P. Ambrosy
- Aly ElezabyAly Elezaby
- Lily K. SternLSLily K. Stern
- Paul P. ChengPCPaul P. Cheng
- David OuyangDODavid Ouyang
Open Access
- 10 November 2026
- journal article
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 32 (11) , 2025-2028
Abstract
No abstract availableFunding Information
- Gordon and Betty Moore Foundation
- Sarnoff Cardiovascular Research Foundation
- National Heart, Lung, and Blood Institute
- American Heart Association
This publication has 4 references indexed in Scilit:
- Effects of Vutrisiran on Cardiac Function and Outcomes in Patients With Transthyretin Amyloidosis With CardiomyopathyJACC, 2025
- The Last Decade in Cardiac AmyloidosisJACC: Cardiovascular Imaging, 2025
- High-Throughput Precision Phenotyping of Left Ventricular Hypertrophy With Cardiovascular Deep LearningJAMA Cardiology, 2022
- Tafamidis treatment delays structural and functional changes of the left ventricle in patients with transthyretin amyloid cardiomyopathyEuropean Heart Journal - Cardiovascular Imaging, 2021